Clinical Trials Browser

OTHER × Interventional × methylnaltrexone × Clear all

NCT06162377 2025-12-17

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.

Phase 4 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT01004393 2016-02-02

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

Phase 2 Completed

12 enrolled 10 charts

Constipation, Opioid-Related Disorders, Neoplasms